The rating assignment is based on a number of factors, including LVHN’s leading market position and history of strong financial performance.
LVHN also faces numerous challenges, including a number of unrestricted investments following its planned capital investment and rapid growth.
The outlook is negative, reflecting Moody’s Investors Service’s expectation that LVHN’s liquidity will remain below expectations.
More articles on healthcare finance:
CFOs name top 6 challenges in 2017
Allina Health’s bottom line takes $104.8M hit from nurse strikes
Insider buying: Tenet director purchases 5k shares
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
